Users of Zepbound or Mounjaro Had Lower Blood Pressure in Study
The patients used tirzepatide, sold as Mounjaro or Zepbound, but researchers could not distinguish the effect of the drug from the effects of weight loss.
Medicare Recipients Can Save on Drugs in 2024
Federal law set caps on some spending for seniors who are enrolled in Part D prescription drug plans. Those paying for high-cost medicines will benefit.
What Is a Yeast Infection? What to Know About Diagnosis and Treatment
There are plenty of effective solutions, experts say. But first you’ll need an accurate diagnosis.
6 Reasons That It’s Hard to Get Your Wegovy and Other Weight-Loss Prescriptions
An array of obstacles make it difficult for patients to obtain Wegovy or Zepbound. Finding Wegovy is “like winning the lottery,” one nurse practitioner said.
U.S. Makes Initial Offers in Medicare Drug Price Negotiations
The offers amount to a starting gun in the price talks between the federal government and the makers of 10 prescription drugs that have been selected for negotiations.
Biogen Abandons Its Controversial Alzheimer’s Drug Aduhelm
The pharmaceutical company will give up its ownership rights to the drug and stop a clinical trial that had been aimed at confirming whether it works.
The Man in Room 117
Andrey Shevelyov would rather live on the street than take antipsychotic medication. Should it be his decision to make?
Buried in Wegovy Costs, North Carolina Will Stop Paying for Obesity Drugs
Starting April 1, state employees in North Carolina will no longer have insurance coverage for costly weight-loss medications like Wegovy and Zepbound.
6 Paperbacks to Read This Week
Recommended reading from the Book Review, including titles by Geraldine Brooks, Jefferson Cowie, Parini Shroff and more.
Six Reasons Drug Prices Are So High in the U.S.
Research shows prices in the United States are nearly double those in other well-off countries.
Call for more information
888-531-0245
info@siii-clinical.com
From research laboratories to clinical settings, SIII integrates the technologies, resources, and expertise our customers need to rise to the next opportunity. SIII is dedicated to exploring and researching the processes and scientific mechanisms underlying the world we live in.